To better characterize these cells, we performed an extensive analysis of their cell-surface receptors early after inclusion (Pt1=Day 1 to 3); NK cells from COVID-19 patients were indistinguishable from those of the healthy donors concerning the following NK receptors: NKG2A, ILT-2 and KIR3DL1 (Supplementary Figure 3). Here, CD177 is linked to COVID-19.